JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
ICF International
ICFI
$1.49B
| $4.89M | ﹤0.01% |
44,601
+429
| +1% | +$44.6K |
2015 Q4
29 quarters
|
|
2727
PUT
W.W. Grainger
GWW
$60.1B
| $4.89M | ﹤0.01% |
7,100
-6,200
| -47% | -$3.95M |
2022 Q3
2 quarters
|
|
|
GLOP
2728
DELISTED
GASLOG PARTNERS LP
GLOP
| $4.88M | ﹤0.01% |
579,492
+568,118
| +4,995% | +$4.58M |
2022 Q3
2 quarters
|
|
2729
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.26B
| $4.85M | ﹤0.01% |
71,752
-48,118
| -40% | -$3.17M |
2013 Q4
37 quarters
|
|
2730
Cheesecake Factory
CAKE
$5.39B
| $4.84M | ﹤0.01% |
138,117
-8,658
| -6% | -$322K |
2013 Q2
39 quarters
|
|
|
NXGN
2731
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.84M | ﹤0.01% |
277,878
-142,154
| -34% | -$2.56M |
2016 Q4
25 quarters
|
|
2732
Cavco Industries
CVCO
$4.4B
| $4.81M | ﹤0.01% |
15,141
+1,371
| +10% | +$379K |
2015 Q4
29 quarters
|
|
2733
Sight Sciences
SGHT
$472M
| $4.81M | ﹤0.01% |
549,846
+9,280
| +2% | +$103K |
2021 Q3
6 quarters
|
|
|
SBOW
2734
DELISTED
SilverBow Resources, Inc.
SBOW
| $4.79M | ﹤0.01% |
209,451
-54,326
| -21% | -$1.34M |
2018 Q3
18 quarters
|
|
2735
Hilltop Holdings
HTH
$2.13B
| $4.78M | ﹤0.01% |
160,981
+15,444
| +11% | +$487K |
2013 Q2
39 quarters
|
|
2736
PUT
The Kraft Heinz Company
KHC
$26.1B
| $4.78M | ﹤0.01% |
123,500
-185,400
| -60% | -$7.34M |
2015 Q4
29 quarters
|
|
|
ELME
2737
Elme Communities
ELME
$156M
| $4.77M | ﹤0.01% |
267,141
+5,345
| +2% | +$97.8K |
2013 Q2
39 quarters
|
|
|
DEA
2738
Easterly Government Properties
DEA
$1.1B
| $4.76M | ﹤0.01% |
138,590
-5,092
| -4% | -$191K |
2015 Q4
29 quarters
|
|
2739
Alpha and Omega Semiconductor
AOSL
$907M
| $4.76M | ﹤0.01% |
176,581
-2,875
| -2% | -$83.5K |
2013 Q2
39 quarters
|
|
|
PPBI
2740
DELISTED
Pacific Premier Bancorp
PPBI
| $4.75M | ﹤0.01% |
197,808
+25,886
| +15% | +$783K |
2016 Q4
25 quarters
|
|
|
DHC
2741
Diversified Healthcare Trust
DHC
$1.84B
| $4.74M | ﹤0.01% |
3,512,241
-667,255
| -16% | -$690K |
2020 Q1
12 quarters
|
|
2742
Virtu Financial
VIRT
$5.44B
| $4.74M | ﹤0.01% |
250,624
+17,555
| +8% | +$337K |
2020 Q1
12 quarters
|
|
|
CBAY
2743
DELISTED
Cymabay Therapeutics
CBAY
| $4.73M | ﹤0.01% |
542,407
+539,415
| +18,029% | +$4.32M |
2018 Q1
20 quarters
|
|
2744
Photronics
PLAB
$1.82B
| $4.73M | ﹤0.01% |
285,187
-29,945
| -10% | -$527K |
2016 Q4
25 quarters
|
|
|
INDT
2745
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $4.73M | ﹤0.01% |
71,313
+52,536
| +280% | +$3.4M |
2017 Q4
21 quarters
|
|
2746
SI-BONE Inc
SIBN
$876M
| $4.73M | ﹤0.01% |
240,306
+14,700
| +7% | +$261K |
2018 Q4
17 quarters
|
|
|
CTIC
2747
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $4.72M | ﹤0.01% |
1,124,714
-61,316
| -5% | -$318K |
2017 Q3
22 quarters
|
|
2748
PUT
United Rentals
URI
$67.3B
| $4.71M | ﹤0.01% |
11,900
+2,700
| +29% | +$1.13M |
2022 Q1
4 quarters
|
|
2749
Glaukos
GKOS
$9.53B
| $4.71M | ﹤0.01% |
93,936
-65,528
| -41% | -$3.18M |
2016 Q1
28 quarters
|
|
2750
Full House Resorts
FLL
$49.8M
| $4.71M | ﹤0.01% |
650,761
+8,386
| +1% | +$72.1K |
2021 Q2
7 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.